National

Feb 22, 2013 12:08 PM by Annie Snead

US approves new targeted breast cancer drug

WASHINGTON (AP) - The U.S. Food and Drug Administration says it has approved a new form of a best-selling breast cancer drug that targets tumor cells while sparing healthy ones.

The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy and a third chemical linking the medicines together. The chemical keeps the drugs intact until they bind to a cancer cell, where the double-shot of medication is released.

The FDA approved the new treatment for about 20 percent of breast cancer patients who have a particular form of the disease. These patients have tumors that overproduce a protein known as HER-2.

The approval will help the Swiss firm build on the success of Herceptin, which has long dominated the breast cancer marketplace. The drug had sales of roughly $6 billion last year.

(Copyright 2013 The Associated Press. All rights reserved.)

 

»Comments

More News

National
Story Photo

1 hour ago

Soldier's remains return

After a decades-long mystery, the family of a World War II soldier finally has some closure. Army Sgt. William Carneal, who disappeared...

Weather - Forecast
Story Photo

15 minutes ago

Cooler Thursday

Windy early with blowing dust in some areas. Wind ending overnight tonight. An isolated thunderstorm possible early. Overnight low temperatures will drop...

Most Popular

Top Videos

1 2 3 4